# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-015019
Filing Date
2026-05-06
Accepted
2026-05-06 08:05:18
Documents
93
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | urgn20260331_10q.htm iXBRL | 10-Q | 1776084
2 | EXHIBIT 10.1 | ex_941915.htm | EX-10.1 | 1323870
3 | EXHIBIT 31.1 | ex_941916.htm | EX-31.1 | 16975
4 | EXHIBIT 31.2 | ex_941917.htm | EX-31.2 | 16981
5 | EXHIBIT 32.1 | ex_941918.htm | EX-32.1 | 6549
6 | EXHIBIT 32.2 | ex_941919.htm | EX-32.2 | 6549
| Complete submission text file | 0001437749-26-015019.txt |  | 9796491

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | urgn-20260331.xsd | EX-101.SCH | 80396
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | urgn-20260331_cal.xml | EX-101.CAL | 60629
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | urgn-20260331_def.xml | EX-101.DEF | 470057
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | urgn-20260331_lab.xml | EX-101.LAB | 435438
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | urgn-20260331_pre.xml | EX-101.PRE | 515863
97 | EXTRACTED XBRL INSTANCE DOCUMENT | urgn20260331_10q_htm.xml | XML | 1146556

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 26945892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)